Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

In recent filings with the Securities and Exchange Commission, Embecta Corp. (NASDAQ:EMBC) Director Morris Milton Mayo reported a series of transactions involving the company's common stock. On ...

Embecta Corp. (NASDAQ:EMBC) announced that its Annual Meeting of Stockholders, which took place on Monday, resulted in the ...